INDV · Indivior Pharmaceuticals, Inc. · Documents

$34.84 +0.07 (+0.20%)

Market Cap

$4.10B

118.01M

Volume · Oct 20 1.93M Avg daily vol (3M) 2.3M

The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.

Type	AI summary	Filing Date	Period
6-K	—	2024-04-26	—
6-K	—	2024-04-25	2024-03-31
6-K	—	2024-04-25	—
6-K	—	2024-04-24	—
6-K	—	2024-04-23	—
6-K	—	2024-04-22	—
6-K	—	2024-04-19	—
6-K	—	2024-04-18	—
6-K	—	2024-04-17	—
6-K	—	2024-04-16	—
6-K	—	2024-04-15	—
6-K	—	2024-04-15	—
6-K	—	2024-04-12	—
6-K	—	2024-04-11	—
6-K	—	2024-04-10	—
6-K	—	2024-04-09	—
6-K	—	2024-04-08	—
6-K	—	2024-04-08	—
6-K	—	2024-04-05	—
6-K	—	2024-04-04	—
6-K	—	2024-04-03	—
6-K	—	2024-04-02	—
6-K	—	2024-04-02	—
6-K	—	2024-03-28	—
6-K	—	2024-03-28	—
6-K	—	2024-03-27	—
6-K	—	2024-03-26	—
6-K	—	2024-03-25	—
6-K	—	2024-03-22	—
6-K	—	2024-03-21	—
6-K	—	2024-03-21	—
6-K	—	2024-03-21	—
6-K	—	2024-03-20	—
6-K	—	2024-03-19	—
6-K	—	2024-03-18	—
6-K	—	2024-03-18	—
6-K	—	2024-03-18	—
6-K	—	2024-03-18	—
6-K	—	2024-03-18	—
6-K	—	2024-03-15	—
6-K	—	2024-03-15	—
6-K	—	2024-03-15	—
6-K	—	2024-03-14	—
6-K	—	2024-03-14	—
6-K	—	2024-03-13	—
6-K	—	2024-03-13	—
6-K	—	2024-03-13	—
6-K	—	2024-03-13	—
6-K/A	—	2024-03-13	—
6-K	—	2024-03-12	—

Showing 201–250 of 386 filings

Key facts CIK 1625297 CUSIP 45579U109 13F (30d) 32 filings 32 filers Visit website Investor relations